Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4
- Medical Info
- Drug Discovery
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 25801
Licensor focuses our research on variations in the untranslated regions of the human genome. Variations in these regions can be used as diagnostic markers to predict or aid in the prediction of susceptibility to disease or to predict a patientâ€™s response to drugs.
Intellectual property (copyrights, know-how and tradenames)
1) CONSITE – Transcription factor site prediction; Transcription factor binding site detection using phylogenetic footprinting; for finding regulatory regions by phylogenetic footprinting.
2) RAVEN – Regulatory Analysis of Variation in Enhancers;
3) GeneLynx – extensible relational database of hyperlinks for each gene within three different genomes (human, rat, mouse); provides information about a particular gene using search identifiers (keyword, accession number, ID, protein or nucleotide sequence).
4) TFBS – Perl modules for transcription factor binding site detection and analysis (open Access)
5) MSCAN – algorithm that detects clusters of transcription factor binding sites in genomic sequences; written in JAVA.
6) JASPAR – transcription factor binding profile database (open access)
IPSCIO Record ID: 203310
Licensor will generate and deliver to Licensee two complete copies of a library consisting of three hundred fifty thousand (350,000) mouse embryonic stem cell clones with Selected Mutations, each identified by DNA sequence of its genomic integration site, the OmniBank II Library. Subject to the terms of this Agreement, Licensor will use Diligent Efforts to generate and deliver the OmniBank II Library in accordance with the schedule set forth in the Development Plan.
Licensor grants to Licensee the non-transferable, non-exclusive right under Licensors rights in the Cre-Lox Patents to use, breed and cross-breed Mutant Mice and Progeny that contain one or more lox sites in their genome (Lox Mice), at the internal research facilities of Licensee, solely for research purposes.
Licensor grants to Licensee a worldwide, non-exclusive right and license to use the Bioinformatics Software, under the copyrights and know-how Controlled by Licensor with respect thereto. Licensee shall have the right under the foregoing license to custom configure the Bioinformatics Software for its internal use.
The Bioinformatics Software means the software for the management and analysis of data relating to the OmniBank II Library and the production, genotyping and phenotypic analysis of knockout mice.
The library, constructed using Licensor's proprietary mouse gene knockout technology, will enable a researcher to develop a mouse that has a specific gene removed or â€œknocked-out.â€ The function of that gene can then be studied by comparing the knockout mouse to a normal mouse. Approximately 99 percent of human genes have a mouse counterpart, and research using this technology may lead to the development of drugs for a wide variety of human and animal diseases, including diabetes and obesity, infectious disease, cancer and heart disease. Institute researchers will have certain rights to utilize Lexiconâ€™s patented gene targeting technologies. In addition, Licensor will equip the Institute with the bioinformatics software required for the management and analysis of data relating to the library.
IPSCIO Record ID: 108170
Licensee may grant sublicenses and licenses, respectively, to the Licensors PathoGenome-TM- Database and Research Collaboration Database to any Third Party only for the purpose of developing, manufacturing, marketing and selling Licensee Products.
Licensor grants the non-exclusive right and license to use the Licensor Technology to research, develop, use, manufacture, have manufactured, market, promote, import, export, sell and have sold Licensee Products and the non-exclusive right and license to use the Licensed Software for the purpose of obtaining access to, pursuing searches in, and/or interpreting or analyzing the data contained in the Research Collaboration Database, the Licensors PathoGenome-TM- Database and other genomic databases which may be or become available to Licensee.
Licensor grants to Licensee the exclusive right and license under its interest in all inventions and under any patents covering such inventions in the Licensees Field which are licensed to Licensor by any Third Party having access to the Licensor PathoGenome-TM- Database under terms in any license relating to the Licensor PathoGenome-TM- Database.
Licensor has expertise in molecular biology, high-throughput sequencing microarrays and the development and utilization of the software tools necessary to assemble, annotate, process, search, manipulate and analyze the genomic sequence information it generates in its research programs (Licensors bioinformatics capability).
The PathoGenomeTM database provides genome sequence information for nearly 30 microbial organisms assembled through Genome Therapeutics’ pathogen genomics research in combination with public domain sources. The database utilizes proprietary bioinformatics software and enables researchers to search for novel target genes among multiple pathogens and cross-reference genomic information.
IPSCIO Record ID: 383582
— For the Layton and Stanford Patent Rights a nonexclusive, non-transferrable, limited sub-licensable, world-wide license under the Layton Patent Rights and the Stanford Patent Rights to practice and use the subject matter within the Layton Patent Rights and the Stanford Patent Rights in the Licensee Database Field of Use, Diagnostic Field of Use, the Homebrew Field of Use and the Personalized Research Field of Use.
— For the Montefiore Patent Rights, a non-transferrable, limited sub-licensable, world-wide license under the Montefiore Patent Rights to practice and use the subject matter within the Montefiore Patent Rights in the Licensee Database Field of Use, the Diagnostic Field of Use, the Homebrew Field of Use and the Personalized Research Field of Use.
— For the Cancer Marker Patent Rights, Licensor grants a non-transferrable, limited sub-licensable, world-wide license under the Cancer Marker Patent Rights to practice and use the subject matter within the Cancer Marker Patent Rights in the Licensee Database Field of Use, the Diagnostic Field of Use, the Homebrew Field of Use and the Personalized Research Field of Use, only with respect to cancer.
— For the Database Patent Rights and Seilhamer/Scott Patent Rights, Licensor grants a nonexclusive, non-transferable, non-sublicensable , world-wide license under the Database Patent Rights and Seilhamer/Scott Patent Rights to practice and use the subject matter within the Database Patent Rights and the Seilhamer/Scott Patent Rights in the Licensee Database Field of Use, the Diagnostic Field of Use, the Homebrew Field of Use, and the Personalized Research Field of Use.
— For the Sublicenses, Licensee shall have the right to grant sublicenses to third parties under such Patent Rights on a Product-by-Product basis to make, use, import, sell, and offer for sale Products developed by Licensee or its Affiliates.
— For the Co-Exclusive Licenses in the Homebrew and Diagnostic Fields of Use, Co-Exclusive shall mean that each Party has the right to exercise all of the rights under the Patent Rights in question in the field of use for which the parties have co-exclusive rights, without obligation to the other except to the extent provided in this Agreement, and neither Party alone has the right to grant sublicenses to third parties under such Patent Rights without express written consent of the other Party.
The patents include
— Processes for Genetic Manipulations Using Promoters;
— Method for Detecting Pathological Conditions;
— Comparative Gene Transcript Analysis; and,
— Methods for Fabricating Micro Arrays of Biological Samples.